Identifier to cite or link to this item:
https://hdl.handle.net/20.500.13003/16726 Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study
Loading...
View
Identifiers
Advisors
Share
Date of defense
Publication date
2011-01
Document type
research article
Citation
Morales R., Cuadrado A., Noguera J. F., Dolz C., Vilella A., Riera J., et al. Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study. Rev Esp Enferm Dig. 2011 Jan;103(1):5-12.
Volume Title
Abstract
Objective: analysis and evaluation of a multidisciplinary approach, postoperative results and survival of a group of patients with resected pancreatic cancer after a multimodal therapy. Design: descriptive, prospective and observational study. Patients: between January 2004 and December 2004, 124 patients with pancreatic cancer were evaluated. In 30 patients pancreatic resection was performed, and they are the object of this study. Results of preoperative evaluation, postoperative morbidity and mortality, and long term survival were studied. Results: diagnostic evaluation was completed in ambulatory basis in 20% of the patients. In 63% of cases, admission was done in the same day of surgery. In 3 patients (9%), tumor resection was not achieved, therefore, concordance between radiological and surgical resectability rate was 91%. Resectability rate was 24.1%. Surgical Mortality was 3.3%, with a global morbidity rate of 56.6%. Survival at one, two, three and, four years was 76.2%, 56.3%, 43%, y 27.3% respectively. Conclusions: technological development and coordination of efforts in multidisciplinary teams offer an accurate evaluation of tumor involvement, and may reduce the number of laparotomies without tumor resection. The application of a systematic and generalized multimodal treatment in pancreatic cancer is progressively showing a tendency of progressive increase in resectability and survival rates in pancreatic cancer.
Description
Publisher version
Research data
Referenced by
It is version of
It is versioned by
Keywords
Pancreatic cancer Multidisciplinary Multimodal Therapy
MeSH
Humans
Adult
Pancreatic Neoplasms
Aged
Aged, 80 and over
Male
Chemotherapy, Adjuvant
Pancreaticoduodenectomy
Stents
Prospective Studies
Hepatectomy
Middle Aged
Antineoplastic Combined Chemotherapy Protocols
Oxaliplatin
Organoplatinum Compounds
Deoxycytidine
Carcinoma
Pancreatectomy
Neoadjuvant Therapy
Kaplan-Meier Estimate
Survival Rate
Colectomy
Female
Patient Care Team
Liver Neoplasms
Cholangiopancreatography, Endoscopic Retrograde
Carcinoma, Pancreatic Ductal
Combined Modality Therapy
Diagnostic Imaging
Aged, 80 and over
Adult
Pancreatic Neoplasms
Aged
Aged, 80 and over
Male
Chemotherapy, Adjuvant
Pancreaticoduodenectomy
Stents
Prospective Studies
Hepatectomy
Middle Aged
Antineoplastic Combined Chemotherapy Protocols
Oxaliplatin
Organoplatinum Compounds
Deoxycytidine
Carcinoma
Pancreatectomy
Neoadjuvant Therapy
Kaplan-Meier Estimate
Survival Rate
Colectomy
Female
Patient Care Team
Liver Neoplasms
Cholangiopancreatography, Endoscopic Retrograde
Carcinoma, Pancreatic Ductal
Combined Modality Therapy
Diagnostic Imaging
Aged, 80 and over
DeCS
Adulto
Colectomía
Neoplasias Pancreáticas
Pancreaticoduodenectomía
Carcinoma Ductal Pancreático
Femenino
Neoplasias Hepáticas
Stents
Masculino
Carcinoma
Hepatectomía
Persona de Mediana Edad
Compuestos Organoplatinos
Estudios Prospectivos
Protocolos de Quimioterapia Combinada Antineoplásica
Desoxicitidina
Estimación de Kaplan-Meier
Quimioterapia Adyuvante
Pancreatectomía
Tasa de Supervivencia
Terapia Combinada
Terapia Neoadyuvante
Colangiopancreatografia Retrógrada Endoscópica
Diagnóstico por Imagen
Grupo de Atención al Paciente
Humanos
Anciano
Anciano de 80 o más Años
Oxaliplatino
Colectomía
Neoplasias Pancreáticas
Pancreaticoduodenectomía
Carcinoma Ductal Pancreático
Femenino
Neoplasias Hepáticas
Stents
Masculino
Carcinoma
Hepatectomía
Persona de Mediana Edad
Compuestos Organoplatinos
Estudios Prospectivos
Protocolos de Quimioterapia Combinada Antineoplásica
Desoxicitidina
Estimación de Kaplan-Meier
Quimioterapia Adyuvante
Pancreatectomía
Tasa de Supervivencia
Terapia Combinada
Terapia Neoadyuvante
Colangiopancreatografia Retrógrada Endoscópica
Diagnóstico por Imagen
Grupo de Atención al Paciente
Humanos
Anciano
Anciano de 80 o más Años
Oxaliplatino












